CVS has capped off an excellent FY21 with a full year outturn ahead of market expectations. It enters FY22 with good momentum, supported by sector tailwinds and further easing of lockdown restrictions. It continues to invest for growth and has balance sheet strength to pursue further targeted acquisitions. We upgrade our current year EPS by 4% and by 3-4% for the outer years, with the risk on the upside. We continue to see CVS as a multi-year growth story with market leadership attributes, opera ....
20 Jul 2021
Exiting FY21 with further upgrades & good momentum
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Exiting FY21 with further upgrades & good momentum
CVS Group plc (CVSG:LON) | 968 58.1 0.6% | Mkt Cap: 694.3m
- Published:
20 Jul 2021 -
Author:
Sahill Shan -
Pages:
3
CVS has capped off an excellent FY21 with a full year outturn ahead of market expectations. It enters FY22 with good momentum, supported by sector tailwinds and further easing of lockdown restrictions. It continues to invest for growth and has balance sheet strength to pursue further targeted acquisitions. We upgrade our current year EPS by 4% and by 3-4% for the outer years, with the risk on the upside. We continue to see CVS as a multi-year growth story with market leadership attributes, opera ....